Therapeutic applications of nanobots and nanocarriers in cancer treatment
Терапевтическое применение наноботов и нанопереносчиков в лечении рака
2025-06-04
SCID: 54.1/2j46name
Discuss with AI
cancer therapynanobotsnanocarriersprecision medicinetargeted drug delivery
Figures from the paper
Abstract (AI)
Cancer remains a pressing global health concern, burdening individuals, families, and healthcare systems worldwide, mainly because of the limited availability of therapeutic options. These days, nanotechnology is revolutionizing cancer research by offering promising drug delivery systems. Among these, nanobots and nanocarriers are key nanotechnology components, offering groundbreaking strategies in cancer therapy by delivering drugs, enhancing diagnostics, and preventing diseases at molecular levels. Nanobots and nanocarriers, engineered at sizes ranging from 1 to 100 nm, demonstrate biocompatibility with cellular systems, offer precise drug delivery, and reduce side effects compared to conventional therapies such as chemotherapy and surgery. Research efforts now focus on transitioning nanobots and nanocarriers from laboratories to clinics, aiming for precision medicine, targeted drug delivery, enhanced therapy efficacy, and minimal side effects. This review aims to highlight the potential of nanobots and nanocarriers in cancer treatment and provide insights into their role in paving the way for clinical applications and improving outcomes in cancer therapy.
Key Findings
1
Current research is focused on translating these technologies from laboratory studies into clinical applications for precision oncology and improved patient outcomes.
2
Nanobots and nanocarriers may improve cancer-treatment efficacy and support disease prevention through localized molecular interventions.
3
Nanobots and nanocarriers, typically measuring 1–100 nm, are highlighted as promising platforms for cancer drug delivery and molecular-level diagnostics.
4
These nanotechnology systems can enable precise, targeted drug delivery while potentially reducing adverse effects compared with conventional chemotherapy and surgery.
Research Object
Nanobots and nanocarriers used in cancer treatment
Research Subject
Their potential for precise, targeted drug delivery, enhanced therapeutic efficacy, improved diagnostics, disease prevention, and reduced side effects, including the transition to clinical applications
Publication Details
Publication Date
2025-06-04
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest